BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review
X An, AK Tiwari, Y Sun, PR Ding, CR Ashby Jr… - Leukemia research, 2010 - Elsevier
Chronic Myeloid Leukemia (CML) is a clonal disease characterized by the presence of the
Philadelphia (Ph+) chromosome and its oncogenic product, BCR-ABL, a constitutively active …
Philadelphia (Ph+) chromosome and its oncogenic product, BCR-ABL, a constitutively active …
Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance
S Shukla, ZS Chen, SV Ambudkar - Drug resistance updates, 2012 - Elsevier
Tyrosine kinases (TKs) are involved in key signaling events/pathways that regulate cancer
cell proliferation, apoptosis, angiogenesis and metastasis. Deregulated activity of TKs has …
cell proliferation, apoptosis, angiogenesis and metastasis. Deregulated activity of TKs has …
Mechanisms of resistance to imatinib and second-generation tyrosine inhibitors in chronic myeloid leukemia
D Milojkovic, J Apperley - Clinical Cancer Research, 2009 - AACR
Targeted therapy in the form of selective tyrosine kinase inhibitors (TKI) has transformed the
approach to management of chronic myeloid leukemia (CML) and dramatically improved …
approach to management of chronic myeloid leukemia (CML) and dramatically improved …
[HTML][HTML] Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance
Tyrosine kinases (TKs) play an important role in pathways that regulate cancer cell
proliferation, apoptosis, angiogenesis and metastasis. Aberrant activity of TKs has been …
proliferation, apoptosis, angiogenesis and metastasis. Aberrant activity of TKs has been …
Endogenous gene and protein expression of drug-transporting proteins in cell lines routinely used in drug discovery programs
G Ahlin, C Hilgendorf, J Karlsson, CAK Szigyarto… - Drug metabolism and …, 2009 - ASPET
The aim of this study was to investigate the gene and protein expression profiles of important
drug-transporting proteins in human cell lines commonly used for studies of drug transport …
drug-transporting proteins in human cell lines commonly used for studies of drug transport …
[HTML][HTML] Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells
F Xu, F Wang, T Yang, Y Sheng, T Zhong… - Cancer cell …, 2014 - Springer
Background Several signal transduction pathways have been reported being involved in the
acquisition of P-glycoprotein (P-gp) mediated multi-drug resistance (MDR) upon exposure to …
acquisition of P-glycoprotein (P-gp) mediated multi-drug resistance (MDR) upon exposure to …
[HTML][HTML] Novel angiotensin receptor blocker, azilsartan induces oxidative stress and NFkB-mediated apoptosis in hepatocellular carcinoma cell line HepG2
E Ahmadian, AY Khosroushahi, A Eftekhari… - Biomedicine & …, 2018 - Elsevier
Overexpression of renin angiotensin system (RAS) components and nuclear factor-kappa B
(NF-kB) has a key role in various cancers. Blockade of RAS and NF-kB pathway has been …
(NF-kB) has a key role in various cancers. Blockade of RAS and NF-kB pathway has been …
[HTML][HTML] Inhibition of NF-κB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related …
TS Jani, J DeVecchio, T Mazumdar, A Agyeman… - Journal of Biological …, 2010 - ASBMB
Colorectal cancer is the third most common malignancy in the United States. Modest
advances with therapeutic approaches that include oxaliplatin (l-OHP) have brought the …
advances with therapeutic approaches that include oxaliplatin (l-OHP) have brought the …
Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL–positive cells
DJ Kominsky, J Klawitter, JL Brown, LG Boros… - Clinical Cancer …, 2009 - AACR
The development of imatinib resistance has become a significant therapeutic problem in
which the etiology seems to be multifactorial and poorly understood. As of today, clinical …
which the etiology seems to be multifactorial and poorly understood. As of today, clinical …
[HTML][HTML] Drug resistance mechanisms in non-small cell lung carcinoma
J Wangari-Talbot, E Hopper-Borge - Journal of cancer research …, 2013 - ncbi.nlm.nih.gov
Lung cancer is the most commonly diagnosed cancer in the world.“Driver” and “passenger”
mutations identified in lung cancer indicate that genetics play a major role in the …
mutations identified in lung cancer indicate that genetics play a major role in the …